{"transactions":[{"id":861276,"issuer":{"id":7219,"kind":"organization","name":"Axil Brands, Inc."},"owners":[{"id":62804,"kind":"person","name":"Ohri Manu","position":1,"cik":"0001424683","reported_name":"Ohri Manu","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-03-04T18:11:36.000Z","date":"2026-01-15","kind":"grant","planned":false,"acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of restricted stock, which will vest on January 15, 2027 and were granted as non-employee director compensation."}],"balance_after":15001,"source":{"system":"sec-edgar","filing":"0001520138-26-000066","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1424683/000152013826000066/ownership.xml","form_type":"4"}},{"id":1304250,"issuer":{"id":7219,"kind":"organization","name":"Axil Brands, Inc."},"owners":[{"id":62804,"kind":"person","name":"Ohri Manu","position":1,"cik":"0001424683","reported_name":"Ohri Manu","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-01-13T06:00:37.000Z","date":"2025-01-13","kind":"grant","planned":false,"acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of restricted stock, which will vest on January 13, 2026 and were granted as non-employee director compensation."}],"balance_after":10001,"source":{"system":"sec-edgar","filing":"0001520138-25-000033","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1424683/000152013825000033/ownership.xml","form_type":"4"}},{"id":1633402,"issuer":{"id":7219,"kind":"organization","name":"Axil Brands, Inc."},"owners":[{"id":62804,"kind":"person","name":"Ohri Manu","position":1,"cik":"0001424683","reported_name":"Ohri Manu","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-02-20T16:32:00.000Z","date":"2024-02-14","kind":"grant","planned":false,"acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This restricted stock award was granted under the Reviv3 Procare Company 2022 Equity Incentive Plan in a transaction exempt under Rule 16b-3 and vests on February 14, 2025, except as otherwise provided in the award notice."}],"balance_after":5001,"source":{"system":"sec-edgar","filing":"0001062993-24-003687","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1424683/000106299324003687/form4.xml","form_type":"4"}},{"id":1807980,"issuer":{"id":7878,"kind":"organization","name":"GT Biopharma, Inc."},"owners":[{"id":62804,"kind":"person","name":"Ohri Manu","position":1,"cik":"0001424683","reported_name":"Ohri Manu","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO & Secretary"}}],"security":"Common Stock","published_at":"2023-08-15T23:26:31.000Z","date":"2023-08-11","kind":"other","planned":false,"acquired":true,"shares":200000,"price":0.287,"value":57400.0,"ownership":{"direct":false,"nature":"By Anarjay Concepts, Inc."},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reporting person transferred the shares without consideration to Anarjay Concepts, Inc., a corporation wholly-owned by the reporting person."}],"balance_after":300000,"source":{"system":"sec-edgar","filing":"0001493152-23-029059","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/109657/000149315223029059/ownership.xml","form_type":"4"}},{"id":1807979,"issuer":{"id":7878,"kind":"organization","name":"GT Biopharma, Inc."},"owners":[{"id":62804,"kind":"person","name":"Ohri Manu","position":1,"cik":"0001424683","reported_name":"Ohri Manu","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO & Secretary"}}],"security":"Common Stock","published_at":"2023-08-15T23:26:31.000Z","date":"2023-08-11","kind":"other","planned":false,"acquired":false,"shares":200000,"price":0.287,"value":57400.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reporting person transferred the shares without consideration to Anarjay Concepts, Inc., a corporation wholly-owned by the reporting person."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001493152-23-029059","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/109657/000149315223029059/ownership.xml","form_type":"4"}},{"id":1807978,"issuer":{"id":7878,"kind":"organization","name":"GT Biopharma, Inc."},"owners":[{"id":62804,"kind":"person","name":"Ohri Manu","position":1,"cik":"0001424683","reported_name":"Ohri Manu","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO & Secretary"}}],"security":"Common Stock","published_at":"2023-08-15T23:26:31.000Z","date":"2023-08-11","kind":"grant","planned":false,"acquired":true,"shares":200000,"price":0.287,"value":57400.0,"ownership":{"direct":true},"balance_after":200000,"source":{"system":"sec-edgar","filing":"0001493152-23-029059","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/109657/000149315223029059/ownership.xml","form_type":"4"}},{"id":1922607,"issuer":{"id":7878,"kind":"organization","name":"GT Biopharma, Inc."},"owners":[{"id":62804,"kind":"person","name":"Ohri Manu","position":1,"cik":"0001424683","reported_name":"Ohri Manu","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO & Secretary"}}],"security":"Common Stock","published_at":"2023-04-10T21:26:50.000Z","date":"2023-04-06","kind":"purchase","planned":false,"acquired":true,"shares":50000,"price":0.5,"value":25000.0,"ownership":{"direct":false,"nature":"By Ohri Family Revocable Trust U/A Dated 02/10/2020"},"balance_after":50000,"source":{"system":"sec-edgar","filing":"0001493152-23-011772","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/109657/000149315223011772/ownership.xml","form_type":"4"}},{"id":2039414,"issuer":{"id":7878,"kind":"organization","name":"GT Biopharma, Inc."},"owners":[{"id":62804,"kind":"person","name":"Ohri Manu","position":1,"cik":"0001424683","reported_name":"Ohri Manu","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Option to purchase Common Stock","published_at":"2023-02-01T11:02:39.000Z","date":"2023-01-27","kind":"grant","acquired":true,"shares":500000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/12th of the shares vest on the monthly anniversary of January 1, 2023 until fully vested, subject to full acceleration in the event the reporting person is involuntarily terminated by the registrant."}],"balance_after":500000,"derivative":{"exercise_price":0.837,"expiration_date":"2033-01-26","underlying":"Common Stock","underlying_shares":500000},"source":{"system":"sec-edgar","filing":"0001493152-23-003227","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/109657/000149315223003227/ownership.xml","form_type":"4"}},{"id":2205916,"issuer":{"id":7878,"kind":"organization","name":"GT Biopharma, Inc."},"owners":[{"id":62804,"kind":"person","name":"Ohri Manu","position":1,"cik":"0001424683","reported_name":"Ohri Manu","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO & Secretary"}}],"security":"Option to purchase Common Stock","published_at":"2022-07-20T01:44:26.000Z","date":"2022-07-15","kind":"grant","acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"66,666 shares on the date of grant, and 66,667 shares on each February 14, 2023 and 2024."}],"balance_after":200000,"derivative":{"exercise_price":2.48,"expiration_date":"2032-07-14","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001493152-22-019872","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/109657/000149315222019872/ownership.xml","form_type":"4"}},{"id":2205915,"issuer":{"id":7878,"kind":"organization","name":"GT Biopharma, Inc."},"owners":[{"id":62804,"kind":"person","name":"Ohri Manu","position":1,"cik":"0001424683","reported_name":"Ohri Manu","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO & Secretary"}}],"security":"Common Stock","published_at":"2022-07-20T01:44:26.000Z","date":"2022-07-15","kind":"other","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Anarjay Concepts, Inc."},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reporting person transferred the shares without consideration to Anarjay Concepts, Inc., a corporation wholly-owned by the reporting person."}],"balance_after":100000,"source":{"system":"sec-edgar","filing":"0001493152-22-019872","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/109657/000149315222019872/ownership.xml","form_type":"4"}},{"id":2205914,"issuer":{"id":7878,"kind":"organization","name":"GT Biopharma, Inc."},"owners":[{"id":62804,"kind":"person","name":"Ohri Manu","position":1,"cik":"0001424683","reported_name":"Ohri Manu","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO & Secretary"}}],"security":"Common Stock","published_at":"2022-07-20T01:44:26.000Z","date":"2022-07-15","kind":"other","acquired":false,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reporting person transferred the shares without consideration to Anarjay Concepts, Inc., a corporation wholly-owned by the reporting person."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001493152-22-019872","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/109657/000149315222019872/ownership.xml","form_type":"4"}},{"id":2205913,"issuer":{"id":7878,"kind":"organization","name":"GT Biopharma, Inc."},"owners":[{"id":62804,"kind":"person","name":"Ohri Manu","position":1,"cik":"0001424683","reported_name":"Ohri Manu","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO & Secretary"}}],"security":"Common Stock","published_at":"2022-07-20T01:44:26.000Z","date":"2022-07-15","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":100000,"source":{"system":"sec-edgar","filing":"0001493152-22-019872","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/109657/000149315222019872/ownership.xml","form_type":"4"}}]}